ELVN icon

Enliven Therapeutics

124 hedge funds and large institutions have $1.19B invested in Enliven Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 57 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
+3
Holders Change %
+2.48%
% of All Funds
1.66%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
24
Increased
57
Reduced
23
Closed
20
Calls
Puts
$14K
Net Calls
-$14K
Net Calls Change
+$3K
Name Holding Trade Value Shares
Change
Shares
Change %
IC
126
Ikarian Capital
Texas
-$5.7M -289,538 Closed
ACP
127
Acuta Capital Partners
California
-$5.22M -265,269 Closed
Lord, Abbett & Co
128
Lord, Abbett & Co
New Jersey
-$3.88M -197,279 Closed
SC
129
Stempoint Capital
New York
-$2.37M -120,430 Closed
BFM
130
Boothbay Fund Management
New York
-$1.51M -76,975 Closed
ECM
131
ExodusPoint Capital Management
New York
-$669K -33,984 Closed
SI
132
Sofinnova Investments
California
-$660K -33,547 Closed
JG
133
Jain Global
New York
-$641K -32,573 Closed
GCM
134
Graham Capital Management
Connecticut
-$394K -19,997 Closed
CF
135
Corebridge Financial
Texas
-$353K -17,925 Closed
Tudor Investment Corp
136
Tudor Investment Corp
Connecticut
-$263K -13,363 Closed
ProShare Advisors
137
ProShare Advisors
Maryland
-$199K -10,125 Closed
ETC
138
Exchange Traded Concepts
Oklahoma
-$119K -6,055 Closed
A
139
AlphaQuest
New York
-$15.3K -776 Closed
CIAM
140
Caitong International Asset Management
Hong Kong
-$4.23K -215 Closed
SSG
141
Summit Securities Group
New York
-$1.5K -76 Closed
Amundi
142
Amundi
France
-$461 -23 Closed
SC
143
Stephens Consulting
Michigan
-$394 -20 Closed
TCM
144
TD Capital Management
Tennessee
-$315 -16 Closed